{"product_id":"new-vistas-in-prostate-cancer-imaging","title":"New Vistas in Prostate Cancer Imaging 2022","description":"\u003cdiv class=\"group-target-audience field-group-div\"\u003e\n\u003cbr\u003e\u003cbr\u003eAs the need to identify and treat prostate cancer increases, imaging is a critical tool in its diagnosis, staging and surveillance.  \u003cstrong\u003e\u003cem\u003eNew Vistas in Prostate Cancer Imaging\u003c\/em\u003e\u003c\/strong\u003e is designed to help radiologists, oncologists, radiation oncologists and urologists master this continually evolving technology.  This activity analyzes the two most promising imaging modalities for prostate cancer: multiparametric MRI and PSMA PET\/CT.  Essential concepts and multiple cases in both modalities are reviewed throughout the course, ensuring the audience a well rounded primer in the visualization and examination of this disease.\u003cbr\u003e\u003cdiv class=\"single-main-content\"\u003e\n\u003cstrong\u003eNew Vistas in Prostate Cancer Imaging\u003c\/strong\u003e\n\u003cbr\u003e\u003chr align=\"center\" width=\"95%\"\u003e\n\u003ctable border=\"0\" cellpadding=\"2\" cellspacing=\"2\" width=\"100%\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003e\u003cstrong\u003eSession 1: Prostate MRI Intro, Protocols and Interpretation\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIntroduction: Continuing and Emerging Roles for  Prostate Imaging\u003c\/td\u003e\n\u003ctd\u003eLouis Mazzarelli, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMastering Multiparametric MRI Prostate Protocols\u003c\/td\u003e\n\u003ctd\u003eAngabeen Khan, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAnatomy of the Prostate With MRI: Pearls and Pitfalls\u003c\/td\u003e\n\u003ctd\u003eLouis Mazzarelli, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGamuts of Prostate mpMRI Interpretation\u003c\/td\u003e\n\u003ctd\u003eLouis Mazzarelli, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003e\u003cstrong\u003eSession 2: PIRADSv2.1,  MRI-Targeted Biopsy \u0026amp; Extra Prostatic Findings\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePIRADSv2.1 Lexicon: Case Based Atlas and Structured Reporting\u003c\/td\u003e\n\u003ctd\u003eLouis Mazzarelli, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCase Conference\u003c\/td\u003e\n\u003ctd\u003eMultiple Speakers\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eQuestions and Answers\u003c\/td\u003e\n\u003ctd\u003eMultiple Speakers\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eExtra Prostatic Findings on mpMRI\u003c\/td\u003e\n\u003ctd\u003eLouis Mazzarelli, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMR\/TRUS Fusion Prostate Biopsy\u003c\/td\u003e\n\u003ctd\u003eJoseph Brito, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMR Directed Biopsy: Inbore Biopsy and Developing Inbore Applications\u003c\/td\u003e\n\u003ctd\u003eLouis Mazzarelli, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003e\u003cstrong\u003eSession 3: Prostate MRI Staging and Controversies\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProstate MRI for Staging of Prostate Cancer\u003c\/td\u003e\n\u003ctd\u003eLouis Mazzarelli, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eControversies in Prostate Imaging: Biparamteric vs mpMRI and Beyond\u003c\/td\u003e\n\u003ctd\u003eLouis Mazzarelli, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eQuestions and Answers\u003c\/td\u003e\n\u003ctd\u003eMultiple Speakers\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCase Conference 2\u003c\/td\u003e\n\u003ctd\u003eMultiple Speakers\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003e\u003cstrong\u003eSession 4: Multiparametric MRI Cases\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003empMRI Case 1\u003c\/td\u003e\n\u003ctd\u003eLouis Mazzarelli, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003empMRI Case 2\u003c\/td\u003e\n\u003ctd\u003eLouis Mazzarelli, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003empMRI Case 3\u003c\/td\u003e\n\u003ctd\u003eLouis Mazzarelli, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003empMRI Case 4\u003c\/td\u003e\n\u003ctd\u003eLouis Mazzarelli, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003empMRI Case 5\u003c\/td\u003e\n\u003ctd\u003eLouis Mazzarelli, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003empMRI Case 6\u003c\/td\u003e\n\u003ctd\u003eLouis Mazzarelli, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003empMRI Case 7\u003c\/td\u003e\n\u003ctd\u003eLouis Mazzarelli, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003empMRI Case 8\u003c\/td\u003e\n\u003ctd\u003eLouis Mazzarelli, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003empMRI Case 9\u003c\/td\u003e\n\u003ctd\u003eLouis Mazzarelli, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003empMRI Case 10\u003c\/td\u003e\n\u003ctd\u003eLouis Mazzarelli, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003empMRI Case 11\u003c\/td\u003e\n\u003ctd\u003eLouis Mazzarelli, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003empMRI Case 12\u003c\/td\u003e\n\u003ctd\u003eLouis Mazzarelli, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003e\u003cstrong\u003eSession 5: Prostate Cancer PET\/CT Imaging Primer\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eThe Basics of Prostate Cancer\u003c\/td\u003e\n\u003ctd\u003eRobert Bridwell, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePET\/CT Applications With FDG and NAF\u003c\/td\u003e\n\u003ctd\u003eRobert Bridwell, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eApproved Functional Imaging\u003c\/td\u003e\n\u003ctd\u003eRobert Bridwell, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePSMA PET\/CT- Ga68 PET\/CT\u003c\/td\u003e\n\u003ctd\u003eRobert Bridwell, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePSMA PET\/CT F-18 Pyl and F-18 1007\u003c\/td\u003e\n\u003ctd\u003eRobert Bridwell, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePSMA Therapy\u003c\/td\u003e\n\u003ctd\u003eRobert Bridwell, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003e\u003cstrong\u003eSession 6: Axumin, PET-C11 Choline and Best Practices\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eThe Changing Prostate Panorama: Axumin (18Fluciclovine) and Its Role in Biochemically Recurrent Prostate Cancer\u003c\/td\u003e\n\u003ctd\u003eLouis Mazzarelli, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePET C-11 Choline Imaging and Other Radiotracers\u003c\/td\u003e\n\u003ctd\u003eMark Muscato, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAppropriate Patient Selection\u003c\/td\u003e\n\u003ctd\u003eRobert Bridwell, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMaximizing Clinical Performance Case Review\u003c\/td\u003e\n\u003ctd\u003eRobert Bridwell, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003e\u003cstrong\u003eSession 7: PSMA PET\/CT Cases\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePSMA PET\/CT Case 1\u003c\/td\u003e\n\u003ctd\u003eRobert Bridwell, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePSMA PET\/CT Case 2\u003c\/td\u003e\n\u003ctd\u003eRobert Bridwell, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePSMA PET\/CT Case 3\u003c\/td\u003e\n\u003ctd\u003eRobert Bridwell, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePSMA PET\/CT Case 4\u003c\/td\u003e\n\u003ctd\u003eRobert Bridwell, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePSMA PET\/CT Case 5\u003c\/td\u003e\n\u003ctd\u003eRobert Bridwell, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePSMA PET\/CT Case 6\u003c\/td\u003e\n\u003ctd\u003eRobert Bridwell, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePSMA PET\/CT Case 7\u003c\/td\u003e\n\u003ctd\u003eRobert Bridwell, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePSMA PET\/CT Case 8\u003c\/td\u003e\n\u003ctd\u003eRobert Bridwell, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePSMA PET\/CT Case 9\u003c\/td\u003e\n\u003ctd\u003eRobert Bridwell, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePSMA PET\/CT Case 10\u003c\/td\u003e\n\u003ctd\u003eRobert Bridwell, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePSMA PET\/CT Case 11\u003c\/td\u003e\n\u003ctd\u003eRobert Bridwell, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePSMA PET\/CT Case 12\u003c\/td\u003e\n\u003ctd\u003eRobert Bridwell, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePSMA PET\/CT Case 13\u003c\/td\u003e\n\u003ctd\u003eRobert Bridwell, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003e\u003cstrong\u003eSession 8:  Community Challenges and Looking Ahead\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd bgcolor=\"#CCCCCC\"\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOvercoming Challenges to Prostate Imaging Within the Community Center\u003c\/td\u003e\n\u003ctd\u003eMark Muscato, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSpace OAR and Beyond: What the Radiation Oncologists Need To Know\u003c\/td\u003e\n\u003ctd\u003eAngabeen Khan, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSeamless Integration of Fusion Biopsy Within the Community Practice: Case Based Approach\u003c\/td\u003e\n\u003ctd\u003eMultiple Speakers\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFuture Horizons for Prostate Imaging: AI, Personalized Care and Prostate Radiogenomics\u003c\/td\u003e\n\u003ctd\u003eLouis Mazzarelli, MD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003cstrong\u003eRelease date: May 1, 2022\u003cbr\u003eExpiration date: April 30, 2025\u003c\/strong\u003e\n\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954438377570,"sku":"MED-AMB03529","price":28.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Pro001_lg-1.jpg?v=1779376730","url":"https:\/\/meducourse.com\/products\/new-vistas-in-prostate-cancer-imaging","provider":"Meducourse","version":"1.0","type":"link"}